Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK

Although the failure of antibiotic treatment is normally attributed to resistance, tolerance and persistence display a significant role in the lack of response to antibiotics. Due to the fact that several nosocomial pathogens show a high level of tolerance and/or resistance to chlorhexidine, in this...

Full description

Bibliographic Details
Main Authors: Ines Bleriot, Lucia Blasco, Mercedes Delgado-Valverde, Ana Gual de Torella, Anton Ambroa, Laura Fernandez-Garcia, Maria Lopez, Jesus Oteo-Iglesias, Thomas K. Wood, Alvaro Pascual, German Bou, Felipe Fernandez-Cuenca, Maria Tomas
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/12/9/566
id doaj-929848321bb34a72ab437a42b9d34a7b
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Ines Bleriot
Lucia Blasco
Mercedes Delgado-Valverde
Ana Gual de Torella
Anton Ambroa
Laura Fernandez-Garcia
Maria Lopez
Jesus Oteo-Iglesias
Thomas K. Wood
Alvaro Pascual
German Bou
Felipe Fernandez-Cuenca
Maria Tomas
spellingShingle Ines Bleriot
Lucia Blasco
Mercedes Delgado-Valverde
Ana Gual de Torella
Anton Ambroa
Laura Fernandez-Garcia
Maria Lopez
Jesus Oteo-Iglesias
Thomas K. Wood
Alvaro Pascual
German Bou
Felipe Fernandez-Cuenca
Maria Tomas
Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK
Toxins
tolerance
persistence
cross-resistance
toxin-antitoxin system
PemI/PemK
<i>Klebsiella pneumoniae</i>
author_facet Ines Bleriot
Lucia Blasco
Mercedes Delgado-Valverde
Ana Gual de Torella
Anton Ambroa
Laura Fernandez-Garcia
Maria Lopez
Jesus Oteo-Iglesias
Thomas K. Wood
Alvaro Pascual
German Bou
Felipe Fernandez-Cuenca
Maria Tomas
author_sort Ines Bleriot
title Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK
title_short Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK
title_full Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK
title_fullStr Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK
title_full_unstemmed Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK
title_sort mechanisms of tolerance and resistance to chlorhexidine in clinical strains of <i>klebsiella pneumoniae</i> producers of carbapenemase: role of new type ii toxin-antitoxin system, pemik
publisher MDPI AG
series Toxins
issn 2072-6651
publishDate 2020-09-01
description Although the failure of antibiotic treatment is normally attributed to resistance, tolerance and persistence display a significant role in the lack of response to antibiotics. Due to the fact that several nosocomial pathogens show a high level of tolerance and/or resistance to chlorhexidine, in this study we analyzed the molecular mechanisms associated with chlorhexidine adaptation in two clinical strains of <i>Klebsiella pneumoniae</i> by phenotypic and transcriptomic studies. These two strains belong to ST258-KPC3 (high-risk clone carrying β-lactamase KPC3) and ST846-OXA48 (low-risk clone carrying β-lactamase OXA48). Our results showed that the <i>K. pneumoniae</i> ST258-KPC3CA and ST846-OXA48CA strains exhibited a different behavior under chlorhexidine (CHLX) pressure, adapting to this biocide through resistance and tolerance mechanisms, respectively. Furthermore, the appearance of cross-resistance to colistin was observed in the ST846-OXA48CA strain (tolerant to CHLX), using the broth microdilution method. Interestingly, this ST846-OXA48CA isolate contained a plasmid that encodes a novel type II toxin/antitoxin (TA) system, PemI/PemK. We characterized this PemI/PemK TA system by cloning both genes into the IPTG-inducible pCA24N plasmid, and found their role in persistence and biofilm formation. Accordingly, the ST846-OXA48CA strain showed a persistence biphasic curve in the presence of a chlorhexidine-imipenem combination, and these results were confirmed by the enzymatic assay (WST-1).
topic tolerance
persistence
cross-resistance
toxin-antitoxin system
PemI/PemK
<i>Klebsiella pneumoniae</i>
url https://www.mdpi.com/2072-6651/12/9/566
work_keys_str_mv AT inesbleriot mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT luciablasco mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT mercedesdelgadovalverde mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT anagualdetorella mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT antonambroa mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT laurafernandezgarcia mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT marialopez mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT jesusoteoiglesias mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT thomaskwood mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT alvaropascual mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT germanbou mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT felipefernandezcuenca mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
AT mariatomas mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik
_version_ 1724449890993438720
spelling doaj-929848321bb34a72ab437a42b9d34a7b2020-11-25T04:00:33ZengMDPI AGToxins2072-66512020-09-011256656610.3390/toxins12090566Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIKInes Bleriot0Lucia Blasco1Mercedes Delgado-Valverde2Ana Gual de Torella3Anton Ambroa4Laura Fernandez-Garcia5Maria Lopez6Jesus Oteo-Iglesias7Thomas K. Wood8Alvaro Pascual9German Bou10Felipe Fernandez-Cuenca11Maria Tomas12Microbiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainClinical Unit for Infectious Diseases, Department of Microbiology and Medicine, Microbiology and Preventive Medicine, Hospital Universitario Virgen Macarena, University of Seville, Biomedicine Insititute of Seville (IBIS), 41009 Seville, SpainClinical Unit for Infectious Diseases, Department of Microbiology and Medicine, Microbiology and Preventive Medicine, Hospital Universitario Virgen Macarena, University of Seville, Biomedicine Insititute of Seville (IBIS), 41009 Seville, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the Behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), 28003 Madrid, SpainDepartment of Chemical Engineering, Pennsylvania State University, University Park, PA 16801, USAStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the Behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), 28003 Madrid, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the Behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), 28003 Madrid, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainAlthough the failure of antibiotic treatment is normally attributed to resistance, tolerance and persistence display a significant role in the lack of response to antibiotics. Due to the fact that several nosocomial pathogens show a high level of tolerance and/or resistance to chlorhexidine, in this study we analyzed the molecular mechanisms associated with chlorhexidine adaptation in two clinical strains of <i>Klebsiella pneumoniae</i> by phenotypic and transcriptomic studies. These two strains belong to ST258-KPC3 (high-risk clone carrying β-lactamase KPC3) and ST846-OXA48 (low-risk clone carrying β-lactamase OXA48). Our results showed that the <i>K. pneumoniae</i> ST258-KPC3CA and ST846-OXA48CA strains exhibited a different behavior under chlorhexidine (CHLX) pressure, adapting to this biocide through resistance and tolerance mechanisms, respectively. Furthermore, the appearance of cross-resistance to colistin was observed in the ST846-OXA48CA strain (tolerant to CHLX), using the broth microdilution method. Interestingly, this ST846-OXA48CA isolate contained a plasmid that encodes a novel type II toxin/antitoxin (TA) system, PemI/PemK. We characterized this PemI/PemK TA system by cloning both genes into the IPTG-inducible pCA24N plasmid, and found their role in persistence and biofilm formation. Accordingly, the ST846-OXA48CA strain showed a persistence biphasic curve in the presence of a chlorhexidine-imipenem combination, and these results were confirmed by the enzymatic assay (WST-1).https://www.mdpi.com/2072-6651/12/9/566tolerancepersistencecross-resistancetoxin-antitoxin systemPemI/PemK<i>Klebsiella pneumoniae</i>